<unk>  is an atypical antipsychotic that is FDA approved for the treatment of patients with hallucinations and delusions associated with Parkinson's disease psychosis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include peripheral edema and confusional state (≥5% and twice the rate of placebo)..
Pimavanserin
Ketanserin
Nabilone
Suvorexant
Icatibant
Carisbamate
Propiomazine
Glafenine